Madhya Pradesh High Court: Victims Must be Given a Hearing Even Before Closure Report Rejection  ||  Delhi HC: Payment of ‘Pagri’ Does Not Render Tenancy Non-Terminable, Allowing Eviction  ||  Ker HC Examined Whether Electro-Homeopathy Can be Practised Without Registration under Medical Laws  ||  Delhi HC: Better Possessory Title Holder Can Recover Property From Occupant Without Superior Right  ||  Bombay High Court: Compensatory Afforestation Must Be in Same or Nearby Locality For Residents  ||  Bombay High Court Protects ‘MEFTAL-SPAS’, Restrains Use of Similar Drug Brand  ||  Supreme Court: Inclusion in Revised Select List Does Not Give TN MV Inspectors a Vested Right  ||  Bombay HC: ICC Cannot Hear Sexual Harassment Complaint over Non-Employer Transport Incident  ||  Ker HC Upholds Rule that Homeopathic Doctors Must Cancel Registration Before Enrolment as Advocates  ||  J&K&L HC: Evidence Negating Penetration Warrants Conviction For Attempt to Rape, Not Rape    

Bombay High Court Protects ‘MEFTAL-SPAS’, Restrains Use of Similar Drug Brand - (19 Jun 2026)

INTELLECTUAL PROPERTY RIGHTS

Bombay HC permanently restrained Alto Healthcare from using the ‘MEFIAL-SPAS’ mark for pain-relief medicine, ruling it deceptively similar to Blue Cross Laboratories’ ‘MEFTAL-SPAS’ trademark. The court held that the name, packaging and overall appearance could mislead consumers, chemists & doctors.

Tags : MEFTAL-SPAS; TRADEMARK; PROTECTS  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved